Kymera Therapeutics Cash Flow Statement
NASDAQ: KYMRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kymera Therapeutics free cash flow
In fiscal 2025, Kymera Therapeutics generated -$232.9 million of operating cash flow and spent $1.4 million on capital expenditures. That left free cash flow of -$234.3 million, a free-cash-flow margin of -597.6% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Kymera Therapeutics cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -311.35M | -223.86M | -146.96M | -154.81M | -100.22M | -45.59M | -41.25M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| Depreciation & Amortization | 8.31M | 7.37M | 3.56M | 2.98M | 2.40M | 1.76M | 825.00K |
| Stock-Based Compensation | 59.90M | 55.01M | 43.12M | 35.48M | 24.97M | 5.19M | 1.20M |
| Change in Working Capital | 23.84M | -46.10M | -5.35M | -33.99M | -60.72M | 120.33M | 55.58M |
| Operating Cash Flow | -232.89M | -194.50M | -102.83M | -153.09M | -128.95M | 88.13M | 17.91M |
| Capital Expenditures | -1.45M | -12.84M | -34.48M | -2.84M | -1.60M | -9.10M | -532.00K |
| Investing Cash Flow | -521.06M | -404.08M | 139.89M | 20.52M | -99.83M | -422.59M | -16.49M |
| Financing Cash Flow | 990.71M | 608.85M | 4.19M | 153.00M | 250.28M | 289.26M | 34.91M |
| Net Change in Cash | 236.76M | 10.27M | 41.25M | 20.43M | 21.50M | -45.20M | 36.33M |
| Free Cash Flow | -234.34M | -207.34M | -137.31M | -155.92M | -130.54M | 79.03M | 17.37M |
This table shows 7 annual periods of Kymera Therapeutics's cash flow statement, from FY 2025 back to FY 2019, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow KYMR's reporting calendar. What is a cash flow statement?